Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Electro-acupuncture Plus PD-1 Inhibitors and Chemotherapy as First-Line Treatment for Metastatic Non-Small Cell Lung Cancer: A Randomized Trial

NCT07337096 is registered in ClinicalTrials.gov with Guangzhou University of Traditional Chinese Medicine as lead sponsor.

NCT NCT07337096
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07337096 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Electro-acupuncture Plus PD-1 Inhibitors and Chemotherapy as First-Line Treatment for Metastatic Non-Small Cell Lung Cancer: A Randomized Trial
Lead sponsor
Guangzhou University of Traditional Chinese Medicine
Phase
Not applicable
Overall status
Recruiting
Start date
January 15, 2026
Completion date
December 31, 2028
Enrollment
424 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

accupuncture, non small cell lung cancer, pd-1 inhibitors